HEADER TOXIN 29-JUN-03 1PVZ TITLE SOLUTION STRUCTURE OF BMP07, A NOVEL POTASSIUM CHANNEL BLOCKER FROM TITLE 2 SCORPION BUTHUS MARTENSI KARSCH, 15 STRUCTURES COMPND MOL_ID: 1; COMPND 2 MOLECULE: K+ TOXIN-LIKE PEPTIDE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: SCORPION NEUROTOXIN, BMP07 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MESOBUTHUS MARTENSII; SOURCE 3 ORGANISM_COMMON: CHINESE SCORPION; SOURCE 4 ORGANISM_TAXID: 34649 KEYWDS ALPHA/BETA SCAFFOLD, TOXIN EXPDTA SOLUTION NMR NUMMDL 15 AUTHOR H.WU,N.ZHANG,Y.WANG,Q.ZHANG,L.OU,M.LI,G.HU REVDAT 4 13-NOV-24 1PVZ 1 REMARK REVDAT 3 20-JUN-18 1PVZ 1 JRNL REMARK REVDAT 2 24-FEB-09 1PVZ 1 VERSN REVDAT 1 18-MAY-04 1PVZ 0 JRNL AUTH N.ZHANG,M.LI,X.CHEN,Y.WANG,G.WU,G.HU,H.WU JRNL TITL SOLUTION STRUCTURE OF BMKK2, A NEW POTASSIUM CHANNEL BLOCKER JRNL TITL 2 FROM THE VENOM OF CHINESE SCORPION BUTHUS MARTENSI KARSCH JRNL REF PROTEINS V. 55 835 2004 JRNL REFN ISSN 0887-3585 JRNL PMID 15146482 JRNL DOI 10.1002/PROT.20117 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : VNMR 6.1B, AMBER 5.0 REMARK 3 AUTHORS : MIKE CARLISLE, DAN STEELE, MIKE MILLER (VNMR), REMARK 3 PETER KOLLMAN, DAVE CASE, KEN MERZ, THOMAS REMARK 3 CHEATHAM, CARLOS SIMMERLING, VERTEX REMARK 3 PHARMACEUTICALS (AMBER) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE STRUCTURES ARE BASED ON A TOTAL OF REMARK 3 277 CONSTRAINTS, 249 ARE NOE-DERIVED DISTANCE CONSTRAINTS, 9 REMARK 3 DIHEDRAL ANGLE CONSTRAINTS, 19 DISTANCE CONSTRAINTS FROM FIVE REMARK 3 HYDROGEN BONDS AND THREE DISULFIDE BONDS. REMARK 4 REMARK 4 1PVZ COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 03-JUL-03. REMARK 100 THE DEPOSITION ID IS D_1000019618. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 300; 300 REMARK 210 PH : 3.0; 2.6 REMARK 210 IONIC STRENGTH : NULL; NULL REMARK 210 PRESSURE : AMBIENT; AMBIENT REMARK 210 SAMPLE CONTENTS : 2.7MM BMP07; 90% H2O, 10% D2O; REMARK 210 2.7MM BMP07; 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : DQF-COSY; 2D NOESY; 2D TOCSY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : VNMR 6.1B, XEASY 1994, DYANA 1.5 REMARK 210 METHOD USED : DISTANCE GEOMETRY REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 15 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: THIS STRUCTURE WAS DETERMINED USING STANDARD 2D REMARK 210 HOMONUCLEAR TECHNIQUES. REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 1 CYS A 13 CA - CB - SG ANGL. DEV. = 7.5 DEGREES REMARK 500 13 CYS A 23 CA - CB - SG ANGL. DEV. = 7.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 PRO A 2 40.86 -78.85 REMARK 500 1 ALA A 4 -141.18 -167.19 REMARK 500 1 ALA A 8 -65.68 -96.93 REMARK 500 1 ASP A 10 -60.60 -29.89 REMARK 500 2 ALA A 4 104.81 73.39 REMARK 500 2 CYS A 7 119.58 -164.15 REMARK 500 2 ASP A 10 -64.21 -20.45 REMARK 500 3 PHE A 3 73.35 -67.08 REMARK 500 3 SER A 14 35.30 -71.50 REMARK 500 3 ARG A 15 -50.82 -151.92 REMARK 500 3 ASN A 20 57.23 35.30 REMARK 500 3 ARG A 24 77.44 -66.30 REMARK 500 3 ASN A 25 79.11 15.87 REMARK 500 4 ALA A 4 111.18 71.83 REMARK 500 4 SER A 14 39.16 -73.40 REMARK 500 4 ARG A 15 -50.15 -148.16 REMARK 500 4 ALA A 29 44.87 -77.99 REMARK 500 5 ALA A 4 85.28 62.05 REMARK 500 5 CYS A 7 118.41 -163.02 REMARK 500 5 SER A 14 37.03 -71.83 REMARK 500 5 ARG A 15 -53.72 -133.15 REMARK 500 5 ASN A 20 65.78 21.41 REMARK 500 6 PHE A 3 107.41 -170.73 REMARK 500 6 ARG A 15 -48.48 -172.87 REMARK 500 7 CYS A 7 119.15 -162.47 REMARK 500 7 ARG A 15 -41.87 -175.04 REMARK 500 7 CYS A 30 60.93 35.72 REMARK 500 8 ALA A 11 -53.36 -29.23 REMARK 500 8 ASN A 20 59.38 32.10 REMARK 500 8 ARG A 24 76.77 -66.88 REMARK 500 8 ASN A 25 83.26 11.62 REMARK 500 8 ALA A 29 44.76 -80.25 REMARK 500 8 CYS A 30 82.74 -69.23 REMARK 500 9 ALA A 4 105.30 -160.43 REMARK 500 9 ALA A 11 -1.81 -55.23 REMARK 500 9 SER A 14 73.11 -67.31 REMARK 500 9 ARG A 15 -49.03 -174.46 REMARK 500 9 ASN A 20 64.07 23.42 REMARK 500 9 ARG A 24 79.74 -66.22 REMARK 500 9 ASN A 25 73.75 33.16 REMARK 500 9 CYS A 30 -70.96 55.31 REMARK 500 10 ALA A 8 -77.94 -129.83 REMARK 500 10 SER A 14 48.38 -73.35 REMARK 500 10 ARG A 15 -52.58 -165.77 REMARK 500 10 ASN A 20 71.44 8.62 REMARK 500 10 ALA A 29 48.66 -79.89 REMARK 500 11 PHE A 3 20.18 -166.77 REMARK 500 11 ARG A 15 -51.52 -177.34 REMARK 500 11 ASN A 20 51.39 33.07 REMARK 500 11 ARG A 24 80.69 -68.91 REMARK 500 REMARK 500 THIS ENTRY HAS 75 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 CYS A 23 ARG A 24 8 145.35 REMARK 500 CYS A 23 ARG A 24 9 149.13 REMARK 500 CYS A 23 ARG A 24 11 147.61 REMARK 500 CYS A 23 ARG A 24 12 147.63 REMARK 500 CYS A 23 ARG A 24 14 144.54 REMARK 500 CYS A 23 ARG A 24 15 146.33 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 2 PHE A 27 0.09 SIDE CHAIN REMARK 500 5 PHE A 27 0.08 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1DU9 RELATED DB: PDB REMARK 900 SOLUTION STRUCTURES OF BMP02, A NATURAL SCORPION TOXIN WHICH BLOCKS REMARK 900 APAMIN-SENSITIVE CALCIUM-ACTIVATED POTASSIUM CHANNEL REMARK 900 RELATED ID: 1PNH RELATED DB: PDB REMARK 900 SOLUTION STRUCTURES OF P05-NH2, A SCORPION TOXIN ANALOG WITH HIGH REMARK 900 AFFINITY FOR THE APAMIN-SENSITIVE POTASSIUM CHANNEL REMARK 900 RELATED ID: 1ACW RELATED DB: PDB REMARK 900 SOLUTION STRUCTURES OF P01, A NATURAL SCORPION PEPTIDE STRUCTURALLY REMARK 900 ANALOGUS TO SCORPION TOXINS SPECIFIC FOR APAMIN-SENSITIVE POTASSIUM REMARK 900 CHANNEL REMARK 900 RELATED ID: 1SCY RELATED DB: PDB REMARK 900 SOLUTION STRUCTURES OF SCYLLATOXIN, A SCORPION TOXIN WITH HIGH REMARK 900 AFFINITY FOR APAMIN-SENSITIVE CALCIUM-ACTIVATED POTASSIUM CHANNELS DBREF 1PVZ A 1 31 UNP Q95NK7 SKK2_MESMA 24 54 SEQRES 1 A 31 THR PRO PHE ALA ILE LYS CYS ALA THR ASP ALA ASP CYS SEQRES 2 A 31 SER ARG LYS CYS PRO GLY ASN PRO PRO CYS ARG ASN GLY SEQRES 3 A 31 PHE CYS ALA CYS THR HELIX 1 1 THR A 9 CYS A 17 1 9 SHEET 1 A 3 ILE A 5 LYS A 6 0 SHEET 2 A 3 PHE A 27 CYS A 28 -1 O CYS A 28 N ILE A 5 SHEET 3 A 3 CYS A 23 ARG A 24 -1 N ARG A 24 O PHE A 27 SSBOND 1 CYS A 7 CYS A 23 1555 1555 2.07 SSBOND 2 CYS A 13 CYS A 28 1555 1555 2.07 SSBOND 3 CYS A 17 CYS A 30 1555 1555 2.07 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1